Berberine as Adjuvant Treatment for Schizophrenia Patients

Clinical trial NCT02983188 · COMPLETED

Trial details

NCT number: NCT02983188
Sponsor: The University of Hong Kong
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Metabolic Syndrome x

Start date: 2018-04-25
Primary completion: 2020-12-30
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.